Prospective Multicentered Safety and Feasibility Pilot for Endobronchial Intratumoral Chemotherapy.

CONCLUSIONS: The injection of paclitaxel after recanalization of MAO in NSCLC patients is safe and feasible using a novel airway injection device.
PMID: 30776363 [PubMed - as supplied by publisher]

Source: Chest - February 15, 2019 Category: Respiratory Medicine Authors: Yarmus L, Mallow C, Akulian J, Lin CT, Ettinger D, Hales R, Voong KR, Lee H, Feller-Kopman D, Semaan R, Seward K, Wahidi MM Tags: Chest Source Type: research